- September 2, 2022
- Newsletter
- 617-430-5616
Menu
» Home » CAD » Cardiology » Cardiac oncology/tumors » Carney complex
ADVERTISEMENT
ADVERTISEMENT
» Home » CAD » Cardiology » Cardiac oncology/tumors » Carney complex
Background
Carney Complex, also known as Carney syndrome or NAME syndrome is a rare genetic disorder characterized by the development of multiple tumors in various parts of the body. The condition is named after Dr. J. Aidan Carney, an American physician who described it in 1985.
Cardiac myxomas are one of the most common and significant manifestations of Carney Complex. These tumors can affect the heart’s function and may lead to various symptoms, such as heart murmurs, palpitations, and in severe cases, cardiac obstruction.
Epidemiology
Carney Complex affects males and females equally and can occur in people of all ethnic backgrounds. The condition is typically diagnosed in adolescence or early adulthood, although some cases have been identified in children and older individuals.
Because of its rarity and the potential for underdiagnosis or misdiagnosis, some cases of Carney Complex may go unreported. Additionally, as medical knowledge and awareness of the syndrome improve, more cases may be identified.
Anatomy
Pathophysiology
The pathophysiology of the Carney Complex primarily revolves around the genetic mutation that causes the condition. Carney Complex is an autosomal dominant disorder caused by mutations in the PRKAR1A gene. This gene provides instructions for making a protein known as the protein kinase A regulatory subunit 1-alpha (PRKAR1A).
Protein kinase A (PKA) is an enzyme that regulates cellular processes and signaling pathways. It helps control the activity of other proteins by adding phosphate groups to them. In turn, phosphorylation can activate or deactivate various cellular functions. The exact mechanisms through which PRKAR1A mutations lead to the development of tumors in Carney Complex are not entirely understood.
However, research suggests that the PRKAR1A gene mutation disrupts the normal functioning of PKA, which can result in uncontrolled cell growth and the formation of tumors. The tumors associated with Carney Complex are primarily benign but can still cause significant health issues due to their size and location.
Etiology
Carney Complex is inherited in an autosomal dominant pattern, meaning a person only needs to inherit one copy of the faulty PRKAR1A gene from either parent to develop the condition. In some cases, the genetic mutation may occur spontaneously (de novo) in an individual with no family history of the syndrome. While most cases of Carney Complex are due to mutations in the PRKAR1A gene, there may be some cases with no identifiable genetic cause.
These cases could be due to other genetic factors or genetic mutations in genes that have not yet been identified or fully characterized. As an autosomal dominant disorder, there is a 50% chance that an affected individual will pass on the mutated gene to each of their children. Consequently, Carney Complex can be present in multiple generations within a family.
Genetics
Prognostic Factors
Carney Complex is considered a chronic condition, and its prognosis is generally favorable compared to other cancerous or malignant conditions. The tumors associated with Carney Complex are predominantly benign myxomas, which do not spread to other parts of the body. However, these tumors can still cause significant health issues due to their size and location, particularly if they affect vital organs like the heart.
Clinical History
Clinical History
Cardiac myxomas are one of the hallmark features of Carney Complex. These are tumors that arise from the inner lining of the heart chambers. Symptoms related to cardiac myxomas may include heart murmurs, palpitations, shortness of breath, and fatigue. In some cases, cardiac myxomas can obstruct blood flow, leading to life-threatening complications like stroke or heart failure.
Individuals with Carney Complex may develop pigmented skin lesions known as lentigines or ephelides. These are flat, brown spots that resemble freckles and can occur on the face, lips, and other sun-exposed areas. Some individuals with Carney Complex may develop myxoid neurofibromas, nerve tumors with a myxoid appearance.
These tumors can lead to neurological symptoms if they compress nearby nerves or nerve roots. A significant clinical aspect of Carney Complex is a positive family history of the disorder. Since it is an autosomal dominant genetic condition, affected individuals often have a parent or other family members with the syndrome.
Physical Examination
Physical Examination
A physical examination may reveal palpable masses in various parts of the body, such as the skin, subcutaneous tissue, or other organs affected by myxomas or other tumors. If endocrine tumors are present, there may be signs and symptoms related to hormonal imbalances. For instance, individuals with adrenal adenomas may exhibit features of Cushing’s syndrome, like weight gain, hypertension, and a moon-shaped face.
Other physical findings associated with secondary conditions like carcinoid tumors or other malignancies may be present depending on the specific tumors involved. The presence of multiple pigmented skin lesions, such as lentigines or ephelides, may be observed on the face, lips, or other sun-exposed areas of the skin.
Age group
Associated comorbidity
Associated activity
Acuity of presentation
Differential Diagnoses
Differential Diagnoses
Adrenal carcinoma
Breast cancer
Intracardiac thrombus
Melanocytic nevi
Lentigo
Primary cardiac neoplasms
Rhabdomyoma
Laboratory Studies
Imaging Studies
Procedures
Histologic Findings
Staging
Treatment Paradigm
Surgical Management
Surgical removal of cardiac myxomas is often the primary treatment to relieve symptoms and prevent complications such as heart obstruction or embolization. Cardiac surgery may require the expertise of a cardiothoracic surgeon. Surgical removal of skin myxomas may be considered for cosmetic reasons or if the tumors cause discomfort or other issues. Surgical removal of adrenal or pituitary adenomas may be necessary to manage hormonal imbalances and related symptoms.
Genetic Counseling
Genetic counseling is recommended for individuals with Carney Complex and their family members to discuss the genetic inheritance pattern and the risk of passing the condition to future generations. It can also help make informed decisions about family planning and genetic testing.
Lifestyle Modifications
As with any chronic medical condition, individuals with Carney Complex may benefit from supportive care, including lifestyle modifications and psychological support, to cope with the challenges of managing the disorder.
by Stage
by Modality
Chemotherapy
Radiation Therapy
Surgical Interventions
Hormone Therapy
Immunotherapy
Hyperthermia
Photodynamic Therapy
Stem Cell Transplant
Targeted Therapy
Palliative Care
Medication
Future Trends
References
ADVERTISEMENT
» Home » CAD » Cardiology » Cardiac oncology/tumors » Carney complex
Carney Complex, also known as Carney syndrome or NAME syndrome is a rare genetic disorder characterized by the development of multiple tumors in various parts of the body. The condition is named after Dr. J. Aidan Carney, an American physician who described it in 1985.
Cardiac myxomas are one of the most common and significant manifestations of Carney Complex. These tumors can affect the heart’s function and may lead to various symptoms, such as heart murmurs, palpitations, and in severe cases, cardiac obstruction.
Carney Complex affects males and females equally and can occur in people of all ethnic backgrounds. The condition is typically diagnosed in adolescence or early adulthood, although some cases have been identified in children and older individuals.
Because of its rarity and the potential for underdiagnosis or misdiagnosis, some cases of Carney Complex may go unreported. Additionally, as medical knowledge and awareness of the syndrome improve, more cases may be identified.
The pathophysiology of the Carney Complex primarily revolves around the genetic mutation that causes the condition. Carney Complex is an autosomal dominant disorder caused by mutations in the PRKAR1A gene. This gene provides instructions for making a protein known as the protein kinase A regulatory subunit 1-alpha (PRKAR1A).
Protein kinase A (PKA) is an enzyme that regulates cellular processes and signaling pathways. It helps control the activity of other proteins by adding phosphate groups to them. In turn, phosphorylation can activate or deactivate various cellular functions. The exact mechanisms through which PRKAR1A mutations lead to the development of tumors in Carney Complex are not entirely understood.
However, research suggests that the PRKAR1A gene mutation disrupts the normal functioning of PKA, which can result in uncontrolled cell growth and the formation of tumors. The tumors associated with Carney Complex are primarily benign but can still cause significant health issues due to their size and location.
Carney Complex is inherited in an autosomal dominant pattern, meaning a person only needs to inherit one copy of the faulty PRKAR1A gene from either parent to develop the condition. In some cases, the genetic mutation may occur spontaneously (de novo) in an individual with no family history of the syndrome. While most cases of Carney Complex are due to mutations in the PRKAR1A gene, there may be some cases with no identifiable genetic cause.
These cases could be due to other genetic factors or genetic mutations in genes that have not yet been identified or fully characterized. As an autosomal dominant disorder, there is a 50% chance that an affected individual will pass on the mutated gene to each of their children. Consequently, Carney Complex can be present in multiple generations within a family.
Carney Complex is considered a chronic condition, and its prognosis is generally favorable compared to other cancerous or malignant conditions. The tumors associated with Carney Complex are predominantly benign myxomas, which do not spread to other parts of the body. However, these tumors can still cause significant health issues due to their size and location, particularly if they affect vital organs like the heart.
Clinical History
Cardiac myxomas are one of the hallmark features of Carney Complex. These are tumors that arise from the inner lining of the heart chambers. Symptoms related to cardiac myxomas may include heart murmurs, palpitations, shortness of breath, and fatigue. In some cases, cardiac myxomas can obstruct blood flow, leading to life-threatening complications like stroke or heart failure.
Individuals with Carney Complex may develop pigmented skin lesions known as lentigines or ephelides. These are flat, brown spots that resemble freckles and can occur on the face, lips, and other sun-exposed areas. Some individuals with Carney Complex may develop myxoid neurofibromas, nerve tumors with a myxoid appearance.
These tumors can lead to neurological symptoms if they compress nearby nerves or nerve roots. A significant clinical aspect of Carney Complex is a positive family history of the disorder. Since it is an autosomal dominant genetic condition, affected individuals often have a parent or other family members with the syndrome.
Physical Examination
A physical examination may reveal palpable masses in various parts of the body, such as the skin, subcutaneous tissue, or other organs affected by myxomas or other tumors. If endocrine tumors are present, there may be signs and symptoms related to hormonal imbalances. For instance, individuals with adrenal adenomas may exhibit features of Cushing’s syndrome, like weight gain, hypertension, and a moon-shaped face.
Other physical findings associated with secondary conditions like carcinoid tumors or other malignancies may be present depending on the specific tumors involved. The presence of multiple pigmented skin lesions, such as lentigines or ephelides, may be observed on the face, lips, or other sun-exposed areas of the skin.
Differential Diagnoses
Adrenal carcinoma
Breast cancer
Intracardiac thrombus
Melanocytic nevi
Lentigo
Primary cardiac neoplasms
Rhabdomyoma
Surgical Management
Surgical removal of cardiac myxomas is often the primary treatment to relieve symptoms and prevent complications such as heart obstruction or embolization. Cardiac surgery may require the expertise of a cardiothoracic surgeon. Surgical removal of skin myxomas may be considered for cosmetic reasons or if the tumors cause discomfort or other issues. Surgical removal of adrenal or pituitary adenomas may be necessary to manage hormonal imbalances and related symptoms.
Genetic Counseling
Genetic counseling is recommended for individuals with Carney Complex and their family members to discuss the genetic inheritance pattern and the risk of passing the condition to future generations. It can also help make informed decisions about family planning and genetic testing.
Lifestyle Modifications
As with any chronic medical condition, individuals with Carney Complex may benefit from supportive care, including lifestyle modifications and psychological support, to cope with the challenges of managing the disorder.
Carney Complex, also known as Carney syndrome or NAME syndrome is a rare genetic disorder characterized by the development of multiple tumors in various parts of the body. The condition is named after Dr. J. Aidan Carney, an American physician who described it in 1985.
Cardiac myxomas are one of the most common and significant manifestations of Carney Complex. These tumors can affect the heart’s function and may lead to various symptoms, such as heart murmurs, palpitations, and in severe cases, cardiac obstruction.
Carney Complex affects males and females equally and can occur in people of all ethnic backgrounds. The condition is typically diagnosed in adolescence or early adulthood, although some cases have been identified in children and older individuals.
Because of its rarity and the potential for underdiagnosis or misdiagnosis, some cases of Carney Complex may go unreported. Additionally, as medical knowledge and awareness of the syndrome improve, more cases may be identified.
The pathophysiology of the Carney Complex primarily revolves around the genetic mutation that causes the condition. Carney Complex is an autosomal dominant disorder caused by mutations in the PRKAR1A gene. This gene provides instructions for making a protein known as the protein kinase A regulatory subunit 1-alpha (PRKAR1A).
Protein kinase A (PKA) is an enzyme that regulates cellular processes and signaling pathways. It helps control the activity of other proteins by adding phosphate groups to them. In turn, phosphorylation can activate or deactivate various cellular functions. The exact mechanisms through which PRKAR1A mutations lead to the development of tumors in Carney Complex are not entirely understood.
However, research suggests that the PRKAR1A gene mutation disrupts the normal functioning of PKA, which can result in uncontrolled cell growth and the formation of tumors. The tumors associated with Carney Complex are primarily benign but can still cause significant health issues due to their size and location.
Carney Complex is inherited in an autosomal dominant pattern, meaning a person only needs to inherit one copy of the faulty PRKAR1A gene from either parent to develop the condition. In some cases, the genetic mutation may occur spontaneously (de novo) in an individual with no family history of the syndrome. While most cases of Carney Complex are due to mutations in the PRKAR1A gene, there may be some cases with no identifiable genetic cause.
These cases could be due to other genetic factors or genetic mutations in genes that have not yet been identified or fully characterized. As an autosomal dominant disorder, there is a 50% chance that an affected individual will pass on the mutated gene to each of their children. Consequently, Carney Complex can be present in multiple generations within a family.
Carney Complex is considered a chronic condition, and its prognosis is generally favorable compared to other cancerous or malignant conditions. The tumors associated with Carney Complex are predominantly benign myxomas, which do not spread to other parts of the body. However, these tumors can still cause significant health issues due to their size and location, particularly if they affect vital organs like the heart.
Clinical History
Cardiac myxomas are one of the hallmark features of Carney Complex. These are tumors that arise from the inner lining of the heart chambers. Symptoms related to cardiac myxomas may include heart murmurs, palpitations, shortness of breath, and fatigue. In some cases, cardiac myxomas can obstruct blood flow, leading to life-threatening complications like stroke or heart failure.
Individuals with Carney Complex may develop pigmented skin lesions known as lentigines or ephelides. These are flat, brown spots that resemble freckles and can occur on the face, lips, and other sun-exposed areas. Some individuals with Carney Complex may develop myxoid neurofibromas, nerve tumors with a myxoid appearance.
These tumors can lead to neurological symptoms if they compress nearby nerves or nerve roots. A significant clinical aspect of Carney Complex is a positive family history of the disorder. Since it is an autosomal dominant genetic condition, affected individuals often have a parent or other family members with the syndrome.
Physical Examination
A physical examination may reveal palpable masses in various parts of the body, such as the skin, subcutaneous tissue, or other organs affected by myxomas or other tumors. If endocrine tumors are present, there may be signs and symptoms related to hormonal imbalances. For instance, individuals with adrenal adenomas may exhibit features of Cushing’s syndrome, like weight gain, hypertension, and a moon-shaped face.
Other physical findings associated with secondary conditions like carcinoid tumors or other malignancies may be present depending on the specific tumors involved. The presence of multiple pigmented skin lesions, such as lentigines or ephelides, may be observed on the face, lips, or other sun-exposed areas of the skin.
Differential Diagnoses
Adrenal carcinoma
Breast cancer
Intracardiac thrombus
Melanocytic nevi
Lentigo
Primary cardiac neoplasms
Rhabdomyoma
Surgical Management
Surgical removal of cardiac myxomas is often the primary treatment to relieve symptoms and prevent complications such as heart obstruction or embolization. Cardiac surgery may require the expertise of a cardiothoracic surgeon. Surgical removal of skin myxomas may be considered for cosmetic reasons or if the tumors cause discomfort or other issues. Surgical removal of adrenal or pituitary adenomas may be necessary to manage hormonal imbalances and related symptoms.
Genetic Counseling
Genetic counseling is recommended for individuals with Carney Complex and their family members to discuss the genetic inheritance pattern and the risk of passing the condition to future generations. It can also help make informed decisions about family planning and genetic testing.
Lifestyle Modifications
As with any chronic medical condition, individuals with Carney Complex may benefit from supportive care, including lifestyle modifications and psychological support, to cope with the challenges of managing the disorder.
Founded in 2014, medtigo is committed to providing high-quality, friendly physicians, transparent pricing, and a focus on building relationships and a lifestyle brand for medical professionals nationwide.
USA – BOSTON
60 Roberts Drive, Suite 313
North Adams, MA 01247
INDIA – PUNE
7, Shree Krishna, 2nd Floor, Opp Kiosk Koffee, Shirole Lane, Off FC Road, Pune 411004, Maharashtra
Founded in 2014, medtigo is committed to providing high-quality, friendly physicians, transparent pricing, and a focus on building relationships and a lifestyle brand for medical professionals nationwide.
MASSACHUSETTS – USA
60 Roberts Drive, Suite 313,
North Adams, MA 01247
MAHARASHTRA – INDIA
7, Shree Krishna, 2nd Floor,
Opp Kiosk Koffee,
Shirole Lane, Off FC Road,
Pune 411004, Maharashtra
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.